Pharmacogenomics in Drug Discovery and Development

Target Discovery for Drug Development Using Mendelian Randomization.- Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.- Pharmacogenomics in Targeted Therapy and Supportive Care Therapies for Cancer.- Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.- Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neuropathy.- The Yin-Yang Dynamics in Cancer Pharmacogenomics and Personalized Medicine.- Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next Generation Sequencing Data.- COVID-19 Pharmacotherapy: Drug Development, Repurposing of Drugs, and the Role of Pharmacogenomics.- Pharmacogenomics Informs Cardiovascular Pharmacotherapy.- Pharmacogenomic Screening of Patient-Specific hiPSC-Derived Cardiomyocyte Drug Candidates Using High-Throughput Calcium Imaging.- The Yin-Yang Dynamics in Cardiovascular Pharmacogenomics and Personalized Medicine.- GTPgS Assay for Measuring Agonist-Induced Desensitization of Two Human Polymorphic Alpha2B-Adrenoceptor Variants.- Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development.- Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.- The Pharmacogenetic Impact on the Pharmacokinetics of ADHD Medications.- Pharmacogenetics of Addiction Therapy.- Pharmacogenomics of Opioid Treatment for Pain Management.- The Role of Pharmacogenomics in Postoperative Pain Management.- Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis.- Pharmacogenomics in Children.- Genetic Ancestry Inference for Pharmacogenomics.